scorecardresearch
Monday, August 11, 2025
TopicDrug Controller General of India

Topic: Drug Controller General of India

India could ‘withdraw’ curbs on drug exports as pharma firms fear loss of business

In a meeting with govt officials, drug-makers flagged concerns that their clients may start buying products from other countries if restrictions on Indian products continued.

Pantop, Lanzol & other top-selling antacids must carry warning about ‘acute kidney injury’

Studies have shown that PPI-based antacids can injure kidneys and reduce their capacity to filter blood effectively.

Govt approves Rs 30 lakh to Rs 1.20 crore compensation for faulty J&J hip implants

Compensation for the faulty J&J hip implants will be the first ever highest paid relief to disabled patients in India, says Drug Controller General of India.

On Camera

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

‘Next war may come sooner than expected, will require whole-of-nation approach’—Army chief

Gen Dwivedi framed Op Sindoor not just as retaliation to Pahalgam, but as demonstration of India’s capability to fight multi-domain conflicts with integration between services & agencies.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.